Introduction
Scrapie in sheep and Creutzfeldt-Jakob disease (CJD) in man are examples of transmissible spongiform encephalopathies (TSEs). After long asymptomatic incubation periods those affected show progressive clinical signs of brain dysfunction ending inevitably in death. These diseases have been highlighted by the recent epizootic of bovine spongiform encephalopathy (BSE) and 10 cases of a new variant form of CJD . Diagnosis of TSEs traditionally depends on post-mortem neuropathological confirmation of clinical signs of the disease. There is no established preclinical diagnostic tool available.
TSEs are caused by a transmissible agent whose structure remains to be determined (Somerville, 1991) . Replication of the infectious agent correlates with the genotype of a host gene, PrP, which encodes the glycoprotein PrP. In sheep several polymorphisms of the PrP gene are found which are associated with susceptibility and\or incubation period, depending on the Author for correspondence : Robert A. Somerville.
Fax j44 131 668 3872. e-mail robert.somerville!bbsrc.ac.uk abnormal form of the protein, PrP Sc , in ruminant brain and spleen has been developed. PrP Sc was detected in sheep spleen extracts from a flock affected by natural scrapie and was also found in spleens from some, but not all, experimental TSE cases. In spleens from cattle with bovine spongiform encephalopathy (BSE) no PrP Sc was detected. It is therefore suggested that there is differential targeting of PrP Sc deposition between organs in these different types of TSE infection which, with other factors, depends on strain of infecting agent.
source or isolate of the agent . Although there are some polymorphisms in the bovine PrP gene, none are associated with BSE incidence in cattle (Goldmann et al., 1991 ; Hunter et al., 1994 b) .
In tissues of scrapie-infected animals PrP is deposited abnormally in a form (PrP Sc ) which can be distinguished from the normal form of the protein (PrP C ) by its sedimentation after detergent treatment and partial resistance to protease digestion (Hope et al., 1986 ; Meyer et al., 1986 ; Somerville et al., 1989) . PrP Sc has been found from early in the incubation period in some mouse models of the disease in brain, spleen and other peripheral organs. The timing and pattern of deposition depends on strain of infecting scrapie agent, Sinc (PrP) genotype of the recipient mouse and route of infection (Farquhar et al., 1994) . In one mouse model of the disease which was derived from the serial passage of BSE infection in mice, PrP Sc was not detected in the peripheral organs examined until late in the incubation period, if at all (Farquhar et al., 1996) . PrP Sc has also been found in brains, spleens and lymph nodes of sheep with natural scrapie (Mohri et al., 1992 ; Race et al., 1992 ; Rubenstein et al., 1987) , and in sheep spleens prior to the time when clinical signs were evident (Ikegami et al., 1991 Muramatsu et al., 1994 ; Schreu$ der et al., 1996 ; Skarphedinsson et al., 1994 ; van Keulen et al., 1996) .
Until recently, confirmation of diagnosis has solely depended on neuropathological examination post-mortem. The detection of PrP Sc has been considered for use as a biochemical confirmation of post-mortem diagnosis or as a potential marker of infection in the living animal (Onodera et al., 1994 ; Schreu$ der et al., 1996 ; Shinagawa et al., 1993) . To develop a simple and sensitive detection system for PrP Sc our strategy has been to use a recombinant source of sheep PrP with which to immunize chickens, thereby increasing antigenic differences between host and immunogen, and hence produce a high-titre antibody reagent. Using the new chicken polyclonal antibody reagents, immunoblotting procedures have been optimized for detecting PrP with high specificity and sensitivity. In addition, a simple extraction method was used in which PrP Sc was concentrated about 1000-fold with respect to PrP C by differential centrifugation. In a second sample PrP C was also removed by digestion with proteinase K prior to differential centrifugation.
Using this methodology a survey was performed on the deposition of PrP Sc in spleens of sheep infected with natural scrapie from the Neuropathogenesis Unit (NPU) flock, where certain PrP genotypes succumb to natural scrapie but other PrP genotypes do not, spleens from field cases of BSE, and available samples from experimental TSEs in sheep. The data show that deposition is model-specific, depending on either the source of infecting agent and possibly the route of infection or the PrP genotype. For example, all tested cases of natural scrapie contained PrP Sc , while cattle with BSE had no detectable PrP Sc in the spleen.
Methods
Recombinant Met-PrP production. The construction of DNA vectors, their expression in E. coli and the purification of recombinant methionyl-PrP (Met-PrP) will be described in detail elsewhere (C. R. Birkett & A. Bennett, unpublished results) . Briefly, the DNA encoding amino acids Lys #& -Ala #%" of the bovine PrP gene (six octapeptide repeat allele ; Goldmann et al., 1991) was expressed intracytoplasmically in E. coli. The 217 amino acid protein was extracted from bacterial paste by solubilization in guanidine-HCl, followed by cation exchange chromatography on SP-Sepharose at pH 8n0 in 6n0 M urea. Met-PrP at a purity of 95 % was dialysed exhaustively against water, and the resulting protein precipitate stored at k80 mC. After solubilization in 1 % SDS, protein was quantified with bicinchoninic acid (micro BCA assay kit, Pierce Chemical) using BSA as standard.
Antisera. Female white leghorn or Rhode Island red fowl were inoculated subcutaneously at two sites each with 0n125 mg Met-PrP suspended in 0n1 ml PBS emulsified with an equal volume of Freund's complete adjuvant. Booster inoculations were done at 3-6 week intervals using the same amount of Met-PrP suspension emulsified with Freund's incomplete adjuvant (subcutaneously) or without any adjuvant intramuscularly into the breast muscle. Pre-immune and test sera were obtained by venepuncture of the wing vein. The birds were brought into lay with a light\dark cycle of 16\8 h and their eggs were stored at 4 mC. Antibody purification. Egg yolk IgG was routinely separated (Akita & Nakai, 1992) from yolk lipoproteins by diluting the yolk with 6 vols ice-cold 10 mM HCl and standing for 16 h, followed by filtration through Whatman no. 1 paper and precipitation with 30 % (w\v) (NH % ) # SO % , all at 0-4 mC. IgG was also prepared by precipitating the yolk lipoprotein with dextran sulphate (Jensenius et al., 1981) or other polyanions (Yokoyama et al., 1993) , followed by precipitation with (NH % ) # SO % as above. Further purification of the IgG was achieved by affinity chromatography or by twice precipitating with 14 % Na # SO % at 20 mC and subsequently either ultrafiltration in a stirred cell over a 100 kDa cut-off filter (Amicon) or by cation exchange chromatography. For cation exchange chromatography the IgG from the final salt precipitation was dissolved in 50 mM MES-NaOH pH 5n0 at between 2 and 5 mg\ml and applied to a 16 mmi25 mm column of SP-Sepharose FF (Pharmacia Biotech) which was developed with a gradient of 0-0n3 M NaCl in 50 mM MES-NaOH pH 5n0, all at 4n0 ml\min and 4 mC. The major IgG peak was identified, by an antibody-capture ELISA using Met-PrP as the target, as a single peak eluting between 50 and 150 mM NaCl and was collected and dialysed exhaustively against PBS. Fabh fragments were prepared according to the method of Akita & Nakai (1993) .
Affinity chromatography. Met-PrP was dissolved at 0n25-2n5 mg\ml in 0n1 M sodium borate buffer pH 8n5 containing 0n1% (w\v) SDS (coupling buffer) by heating at 100 mC for 10 min. A waterequilibrated paste of 1,1h-carbonyldiimidazole-activated 6 % cross-linked beaded agarose (Reacti-Gel 6X, Pierce Chemical) was dispersed in the Met-PrP solution at protein : gel ratios of 1-5 mg\ml gel and incubated, continuously rotating, at room temperature for 24 h. Residual coupling sites were blocked by suspending the drained gel in 10 vols 1n0 M Tris-HCl pH 9n0 for a minimum of 4 h. The Met-PrP-agarose was washed extensively with coupling buffer, transferred to a 9 or 16 mm diameter chromatography column and equilibrated with PBS. The difference in the amount of Met-PrP in solution before and after coupling, measured by a BCA assay (as above), was used to determine the coupling efficiency. Crude IgG from the ammonium sulphate precipitation stage (above), or that resulting from the polyanion precipitations, was dialysed against PBS and applied to the Met-PrP matrix at 0n1 ml\min with buffer re-circulation for 2-4 h. After removing any non-bound IgG with PBS, the PrP-reactive fraction was eluted with 0n1 M glycine-HCl pH 2n3, neutralized with 1n0 M Tris, buffer-exchanged and concentrated using centrifugal ultrafiltration (Centricon 100, Amicon). Solid BSA was added to give 1n0 mg\ml IgG, 10 mg\ml BSA in PBS for protection during storage at 4 mC or k80 mC.
Tissue sources. All sheep samples came from the NPU Cheviot flock (Hunter et al., 1996) , which has been selected into several lines according to susceptibility or resistance to experimental challenge with the SSBP\1 source of experimental sheep scrapie. Depending on PrP genotype, animals in two subgroups of the susceptible line (VV "$' RR "&% QQ "(" and VA "$' RR "&% QQ "(" ) spontaneously develop natural scrapie. Animals which are VA "$' survive if they are also heterozygous at either codon 154 or codon 171 (HR "&% QQ "(" or RR "&% RQ "(" ) but remain susceptible to SSBP\1 experimental challenge. Animals in the resistant line (AA "$' RR\HR\HH "&% QQ\RQ\RR "(" ; Hunter et al., 1996) never develop natural scrapie but are susceptible to experimental challenge with BSE or CH1641 if codon 171 genotype is QQ "(" . Challenged sheep and goats were injected by the subcutaneous (s.c.) or intracerebral (i.c.) routes with brain homogenates from sheep infected with the SSBP\1, CH1641 or spME7 sources of experimental sheep scrapie or field cases of BSE in cattle (Tables 1 and 2 ), challenged mice with the ME7 or 22A strains of mousepassaged sheep scrapie (Dickinson, 1976) 
Fig. 2. Immunoblots of PrP
Sc extracts from sheep brain. The numbers of the groups (see Table 1 ) from which the samples were taken are indicated below the lanes. Samples were extracted with (j) or without (k) proteinase K treatment. Std, PrP C immunostaining in bovine brain homogenate (25 µg). Samples 2 and 6 were from the cortex and medulla respectively of the same animal injected with SSBP/1. Samples 3, 6 and 7 were assessed as positive.
cases of the disease . Genotypes were assigned using published methods (Hunter et al., 1996) . Cattle tissues were from field cases of BSE. Negative-control cattle tissues were taken from healthy animals at a slaughterhouse. All tissues were stored at k70 mC. Tissue extraction. Spleen ( 100 mg) was dissected free of connective tissue ; brain was dissected free of connective tissue and most white matter. Tissue was homogenized in 9 vols 10 mM Tris-HCl pH 7n4 with 25 strokes in a Dounce homogenizer. Two aliquots (240 µl) of the homogenate were mixed for 30 min with 24 ml Sarkosyl (1 %), 100 mM Tris-HCl pH 7n4. PMSF (240 µl of 100 mM in n-propanol) was added to the first aliquot. Proteinase K (60 µl of 20 mg\ml) was added to the second aliquot and incubated for 1 h at room temperature, after which PMSF (240 µl) was added. The samples were centrifuged at 265 000 g (60 000 r.p.m.) for 35 min at 20 mC in the 70 Ti rotor. Pellets were resuspended in 238 µl SDS sample buffer, 2 µl PMSF, heated at 100 mC for 30 min and 50 µl or 100 µl aliquots loaded onto the gel. Extracts from 5 mg brain or 10 mg spleen were found to be the maximum loads resolvable on the gels and therefore were used routinely. SDS-PAGE was performed according to the method of Neville (1971) using 7n5-15 % acrylamide gradient slab gels and protein was transferred (Towbin et al., 1979) to pre-wetted polyvinylidene fluoride membrane (Immobilon-P, Millipore) using a semi-dry blotter. The immunoblot was developed at room temperature using the Boehringer Mannheim chemiluminescent blotting substrate with the following modifications. Blocking was performed with Boehringer Mannheim blocking reagent (one-half of the manufacturer's recommended concentration) in 10 mM Tris-HCl pH 9n0, 100 mM NaCl (TBS) for 30 min (one-half of the manufacturer's recommended time) ; primary antibody (ch1659 at 1 : 2500) was applied overnight in blocking solution. The blot was washed twice with TBS plus 0n1 % Tween 20 (TBST) for 10 min and twice with blocking solution for 10 min, incubated with horseradish peroxidase (HRP)-conjugated rabbit anti-chicken secondary antibody (Jackson) in blocking solution for 90 min and washed four times with TBST. HRP activity was detected using Boehringer Mannheim reagents according to the manufacturer's recommendation. Blots were assessed for the presence of PrP Sc visually or with the aid of a Molecular Dynamics gel scanner. For a sample to be called PrP Sc -positive a typical PrP banding pattern had to be discerned in both sample lanes, i.e. before and after proteinase K digestion. Samples which did not give a clear signal, e.g. because of background interference, were re-extracted.
Results

Immunoblotting of PrP using anti-PrP chicken antibodies
The chicken egg yolk IgG antibodies detected PrP at high titre on immunoblots but their utilization was compromised initially by a high degree of non-specific background staining of non-PrP proteins and of the support membrane. Affinity purification of the antibody (ch1659) from egg yolk minimized both types of background staining. The production of Fabh fragments was also found to be effective (results not shown). PrP C could be detected in 10 µg sheep brain and 100 µg sheep spleen when homogenates were resolved on immunoblots (Fig. 1 ). PrP C from sheep brain had a higher proportion of higher M r forms than that from spleen ( Fig. 1) .
CDJB
Detection of PrP Sc in ruminant brain extracts
Aliquots of 5 mg brain extract from NPU Cheviot sheep or goats with natural scrapie or from animals used in various TSEchallenge experiments were examined for the presence of PrP Sc . Examples of brain extracts examined are shown in Fig.  2 . PrP Sc was found in brain extracts from all nine animals which were diagnosed scrapie-positive with natural scrapie, and six cases of experimental scrapie, based on clinical signs of disease and\or neuropathological confirmation of diagnosis (Table 1) . In most cases a positive signal could be readily observed (e.g. Fig. 2, samples 3 and 7) . However, in one case an animal injected subcutaneously with the SSBP\1 isolate of scrapie was diagnosed clinically positive but the standard pathological examination for vacuolation was negative. Small amounts of PrP Sc could be detected by immunohistochemical staining in the medulla but not the cortex (J. Foster, unpublished results) 
Natural BSE -pos 3\3 0\9 G-4* Natural BSE -pos 12\12  * Data from a previous experimental series (Mohri et al., 1992) .
of this animal. Similarly, PrP Sc could be detected at low levels in extracts from the medulla (Fig. 2 , sample 6) but not cortex (Fig. 2 , sample 2) when brain extracts were immunoblotted. No PrP Sc was detected in brains from any unaffected animals (Fig.  2 , Table 1 ). A previous study had shown that brains from all cattle confirmed as having BSE by histopathological examination were PrP Sc -positive (Table 2 ; Mohri et al., 1992) .
Detection of PrP Sc in ruminant spleen extracts
Aliquots of 10 mg spleen extracts were analysed (Fig. 3) . PrP Sc was detected in extracts from all 16 cases of natural scrapie from the NPU Cheviot flock. Although a clear signal was observed in all samples, the strength of the signal varied (cf. Fig. 2 samples 3, 6 and 7) . PrP Sc was also detected in spleen extracts from nine out of ten animals infected intracerebrally or subcutaneously with the SSBP\1 scrapie isolate (Table 1) . In several cases where a very weak reaction was observed the samples were re-tested to confirm the results. In one i.c.-injected case which was scrapie-positive (Table 1 , group C1) PrP Sc was not detected. The SSBP\1-challenged scrapie cases were from sheep with PrP genotypes which have not developed natural scrapie (VA "$' RR "&% RQ "(" or VA "$' HR "&% QQ "(" ) in the present outbreak in the NPU flock. PrP Sc was not detected in spleen extracts from two goats injected i.c. with SSBP\1 (Table 2, Fig. 3) .
No PrP Sc was found in spleens from sheep (AA "$' ) injected i.c. with the CH1641 isolate (Foster & Dickinson, 1988) . No PrP Sc could be detected in spleen extracts from an animal injected s.c. with another scrapie isolate, spME7 (ME7 strain, passaged in sheep). All animals injected with TSE isolates which failed to succumb to the disease were negative for PrP Sc (Table 1) .
PrP Sc could not be detected in spleen extracts from cattle with BSE (Table 2 ) or in four sheep experimentally injected i.c. with BSE. However, with one other animal injected i.c. and one infected orally, PrP Sc was detected (Table 1) . These two animals differed in their
. BSE has been successfully transmitted to mice from both brain and spleen of the two sheep with PrP Sc -positive spleens (Foster et al., 1996) . No tissues from the other BSE-infected animals have been assayed for infectivity. Four sheep which did not succumb to BSE after an oral or i.c. injection were negative for PrP Sc . Because of their PrP genotypes none of these animals was expected to develop natural scrapie (Hunter et al., 1996) .
Discussion
PrP Sc can be readily detected in extracts of brain and spleen from sheep infected with natural scrapie although the amounts found varied considerably between cases. PrP Sc was also found routinely in spleens of sheep infected experimentally with one source of scrapie (SSBP\1 injected s.c. or i.c.) and spleens of CDJD two sheep infected with BSE. However, in spleens from other experimental models in sheep and from cattle infected with BSE no PrP Sc was detected.
A simple extraction of infected tissue which operationally separates the PrP C and PrP Sc fractions is reported in this paper. The antibody reagent and the methodology described allow the sensitive and specific detection of PrP in ruminant brain and spleen extracts. The chicken antibody reagent could detect PrP C in small amounts of tissue ( 10 µg brain homogenate, 100 µg spleen homogenate) when used at high dilution with high specificity. However, affinity purification was required to avoid background and some non-PrP-specific reactions to other tissue components, particularly in spleen homogenate. The antibody reagent is produced from eggs in large quantities at high titre. In tests for the presence of PrP Sc , tissue extracts of up to 5 mg brain or 10 mg spleen could be successfully resolved and accordingly these amounts were routinely analysed. The method concentrates PrP Sc about 1000-fold with respect to PrP C . In some cases (e.g. the brain sampled in Fig. 2 , samples 2 and 6) the amounts of PrP Sc detected are very low and specific to the region of brain tested. Thus, detection in brain extracts depends on the amount of PrP Sc that has been deposited in the region of brain sampled, i.e. the targeting of lesions and appropriate sampling.
Previous studies of murine models of the TSEs showed that strain of agent, PrP genotype and route of infection could all affect whether and when during the incubation period PrP Sc could be detected in peripheral tissues (Farquhar et al., 1994 (Farquhar et al., , 1996 . In ruminants too these factors may well influence the timing and location of PrP Sc deposition. The data herein, from TSE-infected animals showing clinical signs of disease at the time of death, show that the source of infecting agent was a major factor in determining whether PrP Sc could be detected in sheep spleen extracts. There were insufficient samples available to determine whether the route of infection is of similar importance. However, it is worth noting that although PrP Sc was found in spleens from most peripherally infected animals, in one s.c.-injected case it was not. Similarly PrP Sc was found in spleens from two i.c.-injected cases (SSBP\1-and BSEinjected) but not in six spleens from animals challenged with CH1641 isolate or in five spleens from animals challenged with BSE or SSBP\1. There was also a correlation between PrP genotype and presence or absence of PrP Sc in the spleen extracts from the six BSE-challenged sheep. Spleens from sheep with the genotype (VA "$'
RR "&% RQ "(" ) were negative if challenged with BSE, but positive if challenged with SSBP\1. By contrast, spleens from sheep (AA "$' HR\RR "&% QQ "(" ) which were positive after BSE challenge, were negative after CH1641 challenge. Although these observations do not themselves demonstrate how these three parameters affect PrP Sc deposition they support the concept demonstrated in murine studies (Farquhar et al., 1994 (Farquhar et al., , 1996 that these parameters act in concert to determine the time and location of PrP Sc deposition in peripheral tissues.
Scrapie infectivity has been found in the lymphoreticular system of sheep infected with natural scrapie (Hadlow et al., 1982) , but no infectivity has been found in peripheral tissues of cattle except distal ileum of experimentally infected calves Wells et al., 1994) . However, infectivity has been found in the spleens of two BSE-infected sheep (Foster et al., 1996) in which we have also found PrP Sc . The presence or absence of PrP Sc in spleen correlates with these published results of the distribution of infectivity, but many more examples should be tested before an association can be confirmed.
Selection of particular peripheral tissues in which PrP is deposited and when deposition occurs may be a similar property to the targeting of lesions in the brain (Bruce et al., 1989) . Lesions, and presumably infectivity, may be localized to only small areas of the brain or to selected organs. Diagnosis using PrP can presumably only be made by sampling those tissues or areas of the brain where infection or its sequelae occur.
It is not known what mechanisms control targeting, but presumably agent-specific encoded information interacts with host components to determine whether a cell becomes infected, or whether, once infected, it can replicate the agent. The degree and diversity of glycosylation of PrP (Endo et al., 1989) suggests that these carbohydrate moieties may play a role in target selection, in which context it is interesting to note the difference in degree of glycosylation of PrP in sheep brain and spleen. In contrast to data from brain PrP (Somerville & Ritchie, 1990) , the gel migration data suggest that for most PrP C in sheep spleen only one of the two N-glycosylation sites is utilized. This observation requires further investigation.
In experimental TSEs deposition of PrP in peripheral tissues may be of diagnostic value, but only when it has been ascertained that PrP is always deposited in the tested organ of affected animals in the model of the disease under study. With field scrapie in sheep it would be necessary to show that within an individual flock, assuming a single strain of scrapie is causing the outbreak, proven cases of the disease with similar PrP genotype do have PrP Sc deposited in the organ selected for testing. The data indicate that any PrP deposition in the spleen of BSE-infected cattle, like infectivity, is not detectable and therefore of no potential diagnostic value with present techniques. The absence of infectivity in other peripheral organs of BSE-infected cattle (except distal ileum) suggests little hope for the detection of PrP Sc in non-central nervous system organs in these cases. By contrast, detection of PrP Sc in a lymphoid organ of sheep from the NPU flock with natural scrapie suggests some potential diagnostic value for this approach in sheep if the parameters controlling its deposition are better understood. It will be of value to determine if PrP Sc is deposited in more accessible tissues, e.g. certain lymph nodes. It has recently been reported that PrP Sc can be detected immunohistochemically in the tonsil and other organs in animals from a flock with natural scrapie  CDJE PrP Sc in ruminant spleens PrP Sc in ruminant spleens van Keulen et al., 1996) . However, it will be important to determine if PrP Sc deposition is targeted to lymphoid organs such as spleen or tonsil in flocks in which natural scrapie affects other PrP genotypes .
